HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Jennifer D. Walker Fred A. Crawford Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Walker, J. D. Articles by Spinale, F. G. Search for Related Content PubMed PubMed Citation Articles by Walker, J. D. Articles by Spinale, F. G.

J Thorac Cardiovasc Surg 1994;108:672-679
© 1994 Mosby, Inc.

CARDIOPULMONARY BYPASS, MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES

The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and ß-adrenergic responsiveness in dilated cardiomyopathy

Charleston, S.C.

Supported by National Institutes of Health grant HL45024 (F.G.S.), Established Investigator Award of the American Heart Association (F.G.S.), and Nina S. Braunwald Research Fellowship of the Thoracic Surgery Foundation for Research and Education (J.D.W.).

Received for publication Feb. 28, 1994. Accepted for publication April 18, 1994. Address for reprints: Jennifer D. Walker, MD, Division of Cardiothoracic Surgery, Medical University of South Carolina, 171 Ashley Ave., Charleston, SC 29425.

Abstract

Medical management of patients with chronic left ventricular dysfunction continues to be a difficult problem. Recent clinical and experimental studies have suggested that 3,5,3'-triiodo-L-thyronine improves left ventricular pump function. However, whether 3,5,3'-triiodo-L-thyronine directly improves myocyte contractile function in cardiomyopathic states is unknown. Accordingly, this study examined the direct effects of 3,5,3'-triiodo-L-thyronine on isolated myocyte contractile function in cardiocytes obtained from control (n = 6) pigs and pigs with tachycardia-induced dilated cardiomyopathy (atrial pacing at 240 beats/min for 3 weeks; n = 6). Myocyte percent shortening and velocity of shortening were obtained at baseline and in the presence of 3,5,3'-triiodo-L-thyronine doses of 80 and 100 pmol/L. For both control and dilated cardiomyopathy groups, 3,5,3'-triiodo-L-thyronine caused a significant increase in myocyte contractile function. For example, a 100 pmol/L dose of 3,5,3'-triiodo-L-thyronine increased myocyte velocity of shortening by 51% in control myocytes and by 54% in dilated cardiomyopathy myocytes compared with baseline. A second series of experiments was performed to determine whether 3,5,3'-triiodo-L-thyronine altered the responsiveness of the ß-adrenergic receptor system in control and dilated cardiomyopathy myocytes. Myocyte contractile function was examined during ß-adrenergic stimulation with isoproterenol alone and in myocytes preincubated with 3,5,3'-triiodo-L-thyronine doses of 80 and 100 pmol/L to which isoproterenol was added. Isoproterenol alone increased velocity of shortening by 139% in control and by 233% in dilated cardiomyopathy myocytes compared with baseline. This was significantly greater than the increase with 3,5,3'-triiodo-L-thyronine alone. 3,5,3'-triiodo-L-thyronine followed by isoproterenol increased velocity of shortening by 245% in control and 313% in dilated cardiomyopathy myocytes compared with baseline. This was significantly greater than the response with 3,5,3'-triiodo-L-thyronine or isoproterenol alone and appeared to be greater than an additive response. The results from this study clearly demonstrated that 3,5,3'-triiodo-L-thyronine directly augmented myocyte contractile function in both control and dilated cardiomyopathy myocytes. In addition, 3,5,3'-triiodo-L-thyronine enhanced the contractile response to ß-adrenergic stimulation in dilated cardiomyopathy. This study provides unique evidence to suggest that 3,5,3'-triiodo-L-thyronine may be a useful adjunct to conventional inotropic support in the setting of advanced left ventricular dysfunction. (J THORACCARDIOVASCSURG1994;108:672-9)

This article has been cited by other articles:

				S. Fazio, E. A. Palmieri, G. Lombardi, and B. Biondi Effects of Thyroid Hormone on the Cardiovascular System Recent Prog. Horm. Res., January 1, 2004; 59(1): 31 - 50. [Abstract] [Full Text]

				R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING Nongenomic Steroid Action: Controversies, Questions, and Answers Physiol Rev, July 1, 2003; 83(3): 965 - 1016. [Abstract] [Full Text] [PDF]

				B. M. W. Schmidt, N. Martin, A. C. Georgens, H.-C. Tillmann, M. Feuring, M. Christ, and M. Wehling Nongenomic Cardiovascular Effects of Triiodothyronine in Euthyroid Male Volunteers J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1681 - 1686. [Abstract] [Full Text] [PDF]

				I. Klein and K. Ojamaa Thyroid Hormone and the Cardiovascular System N. Engl. J. Med., February 15, 2001; 344(7): 501 - 509. [Full Text] [PDF]

				E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556. [Abstract] [Full Text] [PDF]

				F. G. Spinale Cellular and molecular therapeutic targets for treatment of contractile dysfunction after cardioplegic arrest Ann. Thorac. Surg., November 1, 1999; 68(5): 1934 - 1941. [Abstract] [Full Text] [PDF]

				N. Murai, Y. Katayama, T. Yamada, T. Imazeki, Y. Irie, H. Kiyama, Y. Sato, I. Hata, H. Yoshida, and M. Mukouyama Thyroid Hormone and Myocardial Metabolism After Heart Surgery in Dogs Asian Cardiovasc Thorac Ann, March 1, 1999; 7(1): 13 - 17. [Abstract] [Full Text] [PDF]

				T. Timek, C.-F. Vahl, A. Bonz, L. Schaffer, M. Rosenberg, and S. Hagl Triiodothyronine reverses depressed contractile performance after excessive catecholamine stimulation Ann. Thorac. Surg., November 1, 1998; 66(5): 1618 - 1625. [Abstract] [Full Text] [PDF]

				W. V. Houck, S. B. Kribbs, J. L. Zellner, M. A. Doscher, J. D. Joshi, F. A. Crawford Jr, and F. G. Spinale Normothermic Versus Hypothermic Hyperkalemic Cardioplegia: Effects on Myocyte Contractility Ann. Thorac. Surg., May 1, 1998; 65(5): 1279 - 1283. [Abstract] [Full Text] [PDF]

				J. D. Walker, F. A. Crawford Jr, and F. G. Spinale 3,5,3'Triiodo-L-Thyronine Pretreatment With Cardioplegic Arrest and Chronic Left Ventricular Dysfunction Ann. Thorac. Surg., August 1, 1995; 60(2): 292 - 299. [Abstract] [Full Text]